Lawson Hannah H

Previous page
1 / 2
You're on page 1
page 2
Next page

Sort by:

Relevance

Page size

Microarray data from YTHDF2-deficient pre-leukemic cells and control pre-leukemic cells

YTHDF2 is overexpressed in a broad spectrum of human acute myeloid leukemias (AML). To study the role of YTHDF2 in leukemia, c-Kit+ cells from foetal livers of Ythdf2fl/fl;Vav-iCre (Ythdf2CKO) and Ythdf2fl/fl (Ythdf2CTL) 14.5 dpc embryos were transduced with Meis1 and Hoxa9 oncogenes and serially re...

ORGANISM(S): Mus musculus

2019-04-05 | E-MTAB-6783 | biostudies-arrayexpress

Temporal analysis of physiological, metabolite and transcriptome responses during drought identifies distinct early and late phases in Arabidopsis

Water availability is the biggest single limitation on plant productivity worldwide. In Arabidopsis, adjustments to drought stress, involving changes in metabolism and gene expression drive increased drought tolerance and initiate diverse drought avoidance and escape responses. To address regulatory...

ORGANISM(S): Arabidopsis thaliana

2016-02-29 | E-GEOD-65046 | biostudies-arrayexpress

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Not available

S-EPMC8084355 | biostudies-literature

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.

Not available

S-EPMC9333998 | biostudies-literature

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Not available

S-EPMC10957483 | biostudies-literature

Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.